脳腫瘍治療薬市場レポート：2030年までの動向、予測、競合分析

脳腫瘍治療薬の動向と予測

世界の脳腫瘍治療薬市場は、2024年から2030年にかけてCAGR 8.7％で成長すると予想されます。この市場の主な促進要因は、喫煙率の上昇、高齢化人口の増加、ストレスや電磁波への暴露です。世界の脳腫瘍治療薬市場は、病院薬局と小売・オンライン薬局市場に機会があり、将来性が期待されます。

セグメント別の脳腫瘍治療薬

この調査には、世界の脳腫瘍治療薬の療法別、適応症別、流通チャネル別、地域別の予測が含まれています。

脳腫瘍治療薬市場の洞察

Lucintelの予測では、脳腫瘍の治療に用いられる補助療法である化学療法が予測期間中最大のセグメントであり続ける。

この市場では、脳腫瘍を治療するための薬剤が処方され、病院内での投与が必要となるため、病院薬局が引き続き大きなセグメントとなると思われます。

北米は、有利な償還政策と新薬の市場投入の増加により、予測期間中最大の地域であり続けると思われます。

よくある質問

Q1.市場の成長予測は：

A1.世界の脳腫瘍治療薬市場は、2024年から2030年にかけてCAGR 8.7%で成長すると予想されています。

Q2.市場の成長に影響を与える主な促進要因は：

A2.この市場の主な促進要因は、喫煙率の上昇、高齢化人口の増加、ストレスや電磁波への暴露です。

Q3.市場の主要セグメントは：

A3.脳腫瘍治療薬市場の将来は、病院薬局市場、小売・オンライン薬局市場に機会があり、有望です。

Q4.市場の主要企業は：

A4.脳腫瘍治療薬の主要企業は以下の通り：

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Q5.今後、最大となる市場セグメントは：

A5.Lucintelは、脳腫瘍の治療に採用される補助療法である化学療法が予測期間中最大のセグメントであり続けると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.北米は、有利な償還政策と新薬の市場投入の増加により、予測期間中も最大の地域です。

Q7.レポートのカスタマイズは可能か：

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の脳腫瘍治療薬市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の脳腫瘍治療薬市場の動向（2018～2023年）と予測（2024～2030年）
• 世界の脳腫瘍治療薬市場：療法別
  • 標的療法
  • 化学療法
  • 免疫療法
  • その他
• 世界の脳腫瘍治療薬市場：適応症別
  • 下垂体
  • 髄膜腫
  • 神経膠腫
  • その他
• 世界の脳腫瘍治療薬市場：流通チャネル別
  • 病院薬局
  • 小売・オンライン薬局

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の脳腫瘍治療薬市場
• 北米の脳腫瘍治療薬市場
• 欧州の脳腫瘍治療薬市場
• アジア太平洋地域の脳腫瘍治療薬市場
• その他地域の脳腫瘍治療薬市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
• 世界の脳腫瘍治療薬市場の新たな動向
• 戦略分析
  • 新製品の開発
  • 世界の脳腫瘍治療薬市場の能力拡大
  • 世界の脳腫瘍治療薬市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Brain Tumor Drug Trends and Forecast

The future of the global brain tumor drug market looks promising with opportunities in the hospital pharmacy and retail & online pharmacy markets. The global brain tumor drug market is expected to grow with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are rising prevalence of smoking, increasing aging population, and stress and exposure to electromagnetic radiation.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Brain Tumor Drug by Segment

The study includes a forecast for the global brain tumor drug by therapy, indication, distribution channel, and region.

Brain Tumor Drug Market by Therapy [Shipment Analysis by Value from 2018 to 2030]:

• Targeted Therapy
• Chemotherapy
• Immunotherapy
• Others

Brain Tumor Drug Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Pituitary
• Meningioma
• Glioma
• Others

Brain Tumor Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Retail & Online Pharmacy

Brain Tumor Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Brain Tumor Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain tumor drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain tumor drug companies profiled in this report include-

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Brain Tumor Drug Market Insights

Lucintel forecasts that chemotherapy will remain the largest segment over the forecast period as it is adjuvant therapy, which is employed for the treatment of brain tumors.

Within this market, hospital pharmacy will remain larger segment as drugs designed to treat the condition are prescribed and necessitate administration within hospital settings.

North America will remain the largest region over the forecast period due to favorable reimbursement policies and rising launch of new drugs in the market.

Features of the Global Brain Tumor Drug Market

Market Size Estimates: Brain tumor drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Brain tumor drug market size by therapy, indication, distribution channel, and region in terms of value ($B).

Regional Analysis: Brain tumor drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapy, indication, distribution channels, and regions for the brain tumor drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain tumor drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for brain tumor drug market?

Answer: The global brain tumor drug market is expected to grow with a CAGR of 8.7% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the brain tumor drug market?

Answer: The major drivers for this market are rising prevalence of smoking, increasing aging population and stress and exposure to electromagnetic radiation.

Q3. What are the major segments for brain tumor drug market?

Answer: The future of the brain tumor drug market looks promising with opportunities in the hospital pharmacy and retail & online pharmacy markets.

Q4. Who are the key brain tumor drug market companies?

Answer: Some of the key brain tumor drug companies are as follows:

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Q5. Which brain tumor drug market segment will be the largest in future?

Answer: Lucintel forecasts that chemotherapy will remain the largest segment over the forecast period as it is adjuvant therapy, which is employed for the treatment of brain tumors.

Q6. In brain tumor drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to favorable reimbursement policies and rising launch of new drugs in the market.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the brain tumor drug market by therapy (targeted therapy, chemotherapy, immunotherapy, and others), indication (pituitary, meningioma, glioma, and others), distribution channel (hospital pharmacy and retail & online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Tumor Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Brain Tumor Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Brain Tumor Drug Market by Therapy
  • 3.3.1: Targeted Therapy
  • 3.3.2: Chemotherapy
  • 3.3.3: Immunotherapy
  • 3.3.4: Others
• 3.4: Global Brain Tumor Drug Market by Indication
  • 3.4.1: Pituitary
  • 3.4.2: Meningioma
  • 3.4.3: Glioma
  • 3.4.4: Others
• 3.5: Global Brain Tumor Drug Market by Distribution Channel
  • 3.5.1: Hospital Pharmacy
  • 3.5.2: Retail & Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Brain Tumor Drug Market by Region
• 4.2: North American Brain Tumor Drug Market
  • 4.2.1: North American Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.2.2: North American Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.3: European Brain Tumor Drug Market
  • 4.3.1: European Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.3.2: European Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.4: APAC Brain Tumor Drug Market
  • 4.4.1: APAC Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.4.2: APAC Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.5: ROW Brain Tumor Drug Market
  • 4.5.1: ROW Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.5.2: ROW Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Brain Tumor Drug Market by Therapy
  • 6.1.2: Growth Opportunities for the Global Brain Tumor Drug Market by Indication
  • 6.1.3: Growth Opportunities for the Global Brain Tumor Drug Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Brain Tumor Drug Market by Region
• 6.2: Emerging Trends in the Global Brain Tumor Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Brain Tumor Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Tumor Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hoffmann-La Roche
• 7.2: Pfizer
• 7.3: Novartis
• 7.4: Amgen
• 7.5: Merck & Co